Relapsed or Refractory Small Lymphocytic Lymphoma
2 clinical trials · Condition
◉ Watch Relapsed or Refractory Small Lymphocytic Lymphoma
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Zanubrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT03206918) | BeiGene | 2017-03-09 |
Track Relapsed or Refractory Small Lymphocytic Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.